Skip to main content

Table 2 Medications and interventions performed on the day 0 or 1 in the unmatched and propensity-matched groups

From: Low-dose corticosteroid treatment and mortality in refractory abdominal septic shock after emergency laparotomy

Variable Unadjusted Propensity-score weighted
Control, n = 2009 Corticosteroid, n = 155 Standardized difference, % Control, n = 2164 Corticosteroid, n = 2101 Standardized difference, %
Blood culture taken 911 (45.3) 76 (49.0) −7.4 987 (45.6) 1005 (47.8) −4.5
Mechanical ventilation 1675 (83.4) 130 (83.9) −1.3 1805 (83.4) 1752 (83.4) 0.1
Intermittent hemodialysis 255 (12.7) 15 (9.7) 9.6 270 (12.5) 229 (10.9) 4.9
Continuous renal replacement therapy 478 (23.8) 31 (20.0) 9.2 509 (23.5) 487 (23.2) 0.8
PMX 515 (25.6) 35 (22.6) 7.1 550 (25.4) 530 (25.2) 0.5
Catecholamines
 Dopamine use 1820 (90.6) 128 (82.6) 23.7 1949 (90.1) 1895 (90.2) −0.4
 Dobutamine use 386 (19.2) 33 (21.3) −5.2 419 (19.4) 449 (21.4) −5.0
 Vasopressin 158 (7.9) 27 (17.4) −29.1 184 (8.5) 154 (7.3) 4.4
Initial antibiotic use
 Initial use of two or more antibiotics 483 (24.0) 38 (24.5) −1.1 521 (24.1) 556 (26.5) −5.5
 Tazobactam/piperacillin or sulbactam/cefoperazone sodium 180 (9.0) 10 (6.5) 9.4 190 (8.8) 214 (10.2) −4.8
 First-generation cephalosporin 93 (4.6) 4 (2.6) 11.0 97 (4.5) 116 (5.5) −4.8
 Second-generation cephalosporin 758 (37.7) 56 (36.1) 3.3 814 (37.6) 810 (38.5) −1.9
 Third-generation cephalosporin 63 (3.1) 5 (3.2) −0.5 68 (3.1) 56 (2.7) 2.8
 Fourth-generation cephalosporin 46 (2.3) 3 (1.9) 2.5 49 (2.3) 39 (1.9) 2.9
 Carbapenem 1248 (62.1) 111 (71.6) −20.3 1359 (62.8) 1357 (64.6) −3.7
Antifungal drug 34 (1.7) 3 (1.9) −1.8 37 (1.7) 41 (2.0) −1.8
Antithrombin 646 (32.2) 57 (36.8) −9.7 703 (32.5) 740 (35.2) −5.8
rhTM 454 (22.6) 38 (24.5) −4.5 492 (22.7) 543 (25.8) −7.2
Gabexate mesilate 517 (25.7) 40 (25.8) −0.2 557 (25.7) 551 (26.2) −1.1
Nafamostat mesilate 947 (47.1) 72 (46.5) 1.4 1019 (47.1) 1006 (47.9) −1.6
Ulinastatin 545 (27.1) 39 (25.2) 4.5 584 (27.0) 493 (23.5) 8.1
Sivelestat sodium 735 (36.6) 51 (32.9) 7.7 786 (36.3) 715 (34.0) 4.8
Immunoglobulin 856 (42.6) 61 (39.4) 6.6 917 (42.4) 845 (40.2) 4.4
Albumin 1614 (80.3) 129 (83.2) −7.5 1743 (80.5) 1761 (83.8) −8.6
Blood transfusion
 Red blood cells 1094 (54.5) 88 (56.8) −4.7 1182 (54.6) 1196 (56.9) −4.6
 Fresh frozen plasma 1065 (53.0) 89 (57.4) −8.9 1154 (53.3) 1090 (51.9) 2.9
 Platelets 254 (12.6) 28 (18.1) −15.1 282 (13.0) 256 (12.2) 2.6
Amount of first blood transfusion
 No. transfusions 833 (41.5) 55 (35.5) 12.3 887 (41.0) 796 (37.9) 6.4
 <500 mL 444 (22.1) 41 (26.5) −10.2 486 (22.5) 535 (25.5) −7.0
 501–1000 mL 556 (27.7) 45 (29.0) −3.0 601 (27.8) 556 (26.5) 2.9
 >1001 mL 176 (8.8) 14 (9.0) −1.0 190 (8.8) 214 (10.2) −4.8
  1. PMX polymyxin B hemoperfusion, rhTM recombinant human soluble thrombomodulin